MLchartDataset catalogue

Pegzerepoetin alfa

Term · Oncology and biomedicine · MLC-T-ONC-015934

A pegylated form of recombinant human erythropoietin, a glycosylated protein naturally produced in the kidney that stimulates erythrocyte production in the bone marrow. Pegzerepoetin alfa may reverse anemias induced by cancer therapy.

Table 1. Record
IdentifierMLC-T-ONC-015934
FieldOncology and biomedicine
Synonymsmethoxy polyethylene glycol-epoetin beta; continuous erythropoietin receptor activator
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-015934",
  "term": "Pegzerepoetin alfa",
  "field": "Oncology and biomedicine",
  "definition": "A pegylated form of recombinant human erythropoietin, a glycosylated protein naturally produced in the kidney that stimulates erythrocyte production in the bone marrow. Pegzerepoetin alfa may reverse anemias induced by cancer therapy.",
  "synonyms": [
    "methoxy polyethylene glycol-epoetin beta",
    "continuous erythropoietin receptor activator"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/pegzerepoetin-alfa/"
}

Record 12,875 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.